AI for in-silico prioritization
in healthy ageing research
A virtual aged-tissue model — an AI-based New Approach Methodology that predicts and ranks the response of physiologically aged tissue to geroprotective interventions in silico, benchmarked to reduce and replace animal screening.
Reducing uncertainty before validation
Healthy-ageing research requires better ways to prioritize intervention candidates before costly and time-consuming validation studies. GEROTWIN is designed to support earlier, evidence-informed decision-making through high-level computational modeling
What makes GEROTWIN unique
Predicts how aged tissue is expected to respond to senolytics, partial reprogramming, rapamycin-class compounds and related interventions before laboratory testing.
Trained on physiologically aged single-cell atlases rather than young or transformed cell lines.
Counterfactual intervention simulation
Foundation model for aged tissue
Decision-grade uncertainty
Ranks intervention candidates together with calibrated confidence estimates, supporting experimental prioritization rather than replacing scientific judgement.
01
02
03
ArcentLabs
In-silico prioritization for translational ageing biology
Home-GEROTWIN-About-Contact
Contact
partnership@arcentlabs.com
© 2026 ArcentLabs-Computational prioritization for translational ageing biology.
ARCENTLABS • GEROTWIN
